STAT July 10, 2019
Katy Milani

It isn’t lost on the public that the pharmaceutical industry is putting profits over people. Over 80% of Americans across party lines believe that lowering drug costs should be a “top priority” for lawmakers. Policymakers across the political spectrum have put the industry on notice, holding hearings with pharmaceutical company CEOs and introducing a flurry of policies to rein in high-cost medicines.

President Trump also made lowering drug costs a priority, and went as far as accusing drugmakers of “getting away with murder” on the campaign trail.

Yet the industry continues to operate as if it’s business as usual, putting profits over people’s health. Case in point: the second-largest pharmaceutical merger this year made headlines in late June with a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Trends
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders
Lene Oddershede Discusses Upcoming Projects from the Novo Nordisk Foundation

Share This Article